SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) (USD $)
In Millions, unless otherwise specified |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2012
|
Dec. 31, 2011
|
Dec. 31, 2010
|
|
Goodwill. | |||
Goodwill | $ 445 | $ 339 | $ 367 |
Percentage of total goodwill, emissions solutions and filtration | 90.00% | ||
Warranty | |||
Total receivables related to estimated supplier recoveries | 13 | 14 | |
Receivables related to estimated supplier recoveries, Current portion | 7 | 7 | |
Receivables related to estimated supplier recoveries, Long-term portion | 6 | 7 | |
Research and Development | |||
Research and development expenses, net of contract reimbursements | 721 | 621 | 402 |
Contract reimbursements | $ 86 | $ 75 | $ 68 |
X | ||||||||||
- Definition
This element represents the percentage of total goodwill as of the balance sheet date. No definition available.
|
X | ||||||||||
- Definition
This item represents the receivables related to estimated supplier recoveries for warranty expenses. No definition available.
|
X | ||||||||||
- Definition
This item represents the current portion of the total receivables related to estimated supplier recoveries. No definition available.
|
X | ||||||||||
- Definition
This item represents the noncurrent portion of the total receivables related to estimated supplier recoveries. No definition available.
|
X | ||||||||||
- Definition
Research and development costs, excluding engineering, incurred for product improvement, innovation and cost reductions. No definition available.
|
X | ||||||||||
- Definition
This element represents the amount of contract reimbursements related to research and development (R&D). No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|